AXA Framlington Biotech Fund R USD AccRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/04/2024 |
|
Annual Returns (GBP) | 30/04/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |
Price Return | 9.01 | -7.04 | 17.52 | 31.57 | 2.03 | 3.59 | 0.96 | -1.74 |
+/- Category | -1.28 | 0.92 | -2.68 | 5.60 | 11.06 | 11.42 | 2.25 | 2.07 |
+/- Category Index | -6.18 | -5.19 | 0.81 | -1.37 | 1.73 | 1.12 | -6.37 | -8.18 |
% Rank in Category | 63 | 54 | 66 | 19 | 20 | 24 | 33 | 38 |
Trailing Returns (GBP) | 09/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.70 | -1.05 | -0.96 |
1 Week | 1.35 | -2.50 | -0.32 |
1 Month | 0.68 | -0.44 | -1.75 |
3 Months | -0.68 | -2.53 | -5.79 |
6 Months | 12.17 | -0.42 | -1.42 |
YTD | 1.01 | 0.62 | -8.16 |
1 Year | 3.63 | 1.65 | -11.58 |
3 Years Annualised | 4.79 | 8.60 | -4.22 |
5 Years Annualised | 8.11 | 1.44 | -4.52 |
10 Years Annualised* | 10.26 | 0.24 | -1.82 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 4.24 | - | - | - |
2023 | -4.18 | -1.84 | 1.08 | 6.20 |
2022 | -8.70 | -0.26 | 14.97 | -1.05 |
2021 | -6.53 | 8.44 | 4.34 | -3.53 |
2020 | 0.05 | 28.49 | -2.58 | 5.06 |
2019 | 16.22 | -1.09 | -9.15 | 12.54 |
|
Advertisement |